Therapeutics 1

Details

Title

Therapeutics 1

Type

Stage One

Module code

HLS018

Requirement

Compulsory

Module objective

By the end of the training period trainees will, in respect of the modes of action and appropriate use of immunosuppressive drugs and other therapies appropriate to immunology*, be able to:

• analyse, synthesise, evaluate and apply knowledge
• perform a range of technical and clinical skills and procedures
• demonstrate the attitudes and behaviours necessary for professional practice as a consultant clinical scientist dealing with the complexities, uncertainties and tensions of professional practice at this level.

*CyA

MMF
Tacro
Aza
Cyroines and their inhibitors and modulators.

Knowledge and understanding

By the end of the training period the trainee will be able to demonstrate the ability to analyse, evaluate and synthesise relevant knowledge and its application to their professional practice in relation to:

• appropriate laboratory investigations
• therapeutic interventions:
  • putative mechanisms of action of various immunological therapies
  • principles of the various therapeutic options to guide the most appropriate treatment for an individual patient.
• the mechanisms of conventional anti-inflammatory drugs (NASIDS, MTX) and corticosteroids
• the mechanisms of recombinant proteins including cytokines, cytokine antagonists, ligand antagonists, monoclonal antibodies
• the mechanisms of vaccines
• for immunoglobulin, the manufacture, supply, mechanisms of action and side effects.

Technical and clinical skills

By the end of the training period the trainee will be able to apply knowledge of immunosuppressive drugs and other therapies appropriate to immunology, to perform the clinical skills necessary to manage under supervision the following. Understanding of:

• history taking
• physical examination
• selection of appropriate ancillary investigations
• formulating differential diagnoses.

To use knowledge of therapeutic options and understanding of the principles of their actions to aid clinical decision making.

Familiarity with national guidance on appropriate test selection and use where relevant, e.g. NICE.